• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缓释抗抑郁药使用中的药物复杂性和可负担性。

Medication complexity and affordability in use of time release antidepressants.

作者信息

Hong Song H, Al-Ruthia Yazed, Tak Sunghee

机构信息

Department of Clinical Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

出版信息

Clin Transl Sci. 2014 Oct;7(5):376-83. doi: 10.1111/cts.12174. Epub 2014 Jun 5.

DOI:10.1111/cts.12174
PMID:24898693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5350880/
Abstract

While time-release (TR) formulations reduce medication complexity, their increased costs may compromise medication affordability. This study examined how medication complexity and affordability affect the extent of access to TR formulations among adult patients with depression. Study subjects consisted of adults (≥ 24 years old) with reported diagnoses of depression from the 2010 Medical Expenditure Panel Survey (MEPS). Antidepressants that offer choices between TR vs. IR (immediate release) were selected. Factors related to medication complexity and affordability were identifi ed based on the Andersonfs model of health services utilization. A multivariate logistic regression was used to examine the study hypotheses while controlling for complex survey sampling in MEPS. A total of 625 working adults with depression had fi lled prescriptions with TR formulations about 60% of the time. Factors related to medication affordability and complexity were signifi cantly associated with the extent of access to TR antidepressant formulations. Identifi cation of those factors associated with the use of TR formulations would contribute to improving access as well as adherence to antidepressant drug therapy.

摘要

虽然缓释(TR)制剂降低了用药复杂性,但其成本增加可能会影响药物的可负担性。本研究调查了用药复杂性和可负担性如何影响成年抑郁症患者使用TR制剂的程度。研究对象包括2010年医疗支出面板调查(MEPS)中报告诊断为抑郁症的成年人(≥24岁)。选择了在TR和速释(IR)之间有选择的抗抑郁药。基于安德森卫生服务利用模型确定了与用药复杂性和可负担性相关的因素。在控制MEPS复杂调查抽样的同时,使用多元逻辑回归检验研究假设。共有625名患有抑郁症的在职成年人约60%的时间使用TR制剂开具处方。与用药可负担性和复杂性相关的因素与使用TR抗抑郁制剂的程度显著相关。确定与使用TR制剂相关的因素将有助于改善抗抑郁药物治疗的可及性和依从性。

相似文献

1
Medication complexity and affordability in use of time release antidepressants.缓释抗抑郁药使用中的药物复杂性和可负担性。
Clin Transl Sci. 2014 Oct;7(5):376-83. doi: 10.1111/cts.12174. Epub 2014 Jun 5.
2
Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.与遵循美国国家质量保证委员会(NCQA)医疗效果数据和信息集(HEDIS)抗抑郁药物管理措施相关的更高成本和治疗因素:行政索赔分析
J Manag Care Pharm. 2006 Jan-Feb;12(1):43-54. doi: 10.18553/jmcp.2006.12.1.43.
3
Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.药物依从性和医疗资源利用模式的差异:老年与新型抗抑郁药在抑郁症和/或焦虑症患者中的应用
CNS Drugs. 2008;22(11):963-73. doi: 10.2165/00023210-200822110-00005.
4
Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.文拉法辛与选择性5-羟色胺再摄取抑制剂(SSRI)抗抑郁治疗药物相互转换治疗重度抑郁症的药学及医疗成本。
J Manag Care Pharm. 2008 Jun;14(5):426-41. doi: 10.18553/jmcp.2008.14.5.426.
5
Association Between Cognitive Function and Health Care Costs 3 Months and 6 Months After Initiating Antidepressant Medication for Depressive Disorders.抑郁障碍患者开始服用抗抑郁药物后 3 个月和 6 个月时认知功能与医疗保健费用的相关性。
J Manag Care Spec Pharm. 2015 Sep;21(9):742-52, 752a-752e. doi: 10.18553/jmcp.2015.21.9.742.
6
Antidepressant prescriptions and mental health nurses: an observational study in Dutch general practice from 2011 to 2015.抗抑郁药处方与心理健康护士:一项2011年至2015年荷兰全科医疗的观察性研究。
Scand J Prim Health Care. 2018 Mar;36(1):47-55. doi: 10.1080/02813432.2018.1426145. Epub 2018 Jan 17.
7
Impact of antidepressant drug adherence on comorbid medication use and resource utilization.抗抑郁药物依从性对合并用药及资源利用的影响。
Arch Intern Med. 2005 Nov 28;165(21):2497-503. doi: 10.1001/archinte.165.21.2497.
8
The relationship of antidepressant prescribing concentration to treatment duration and cost.抗抑郁药物处方浓度与治疗持续时间及成本的关系。
J Ment Health Policy Econ. 2012 Mar;15(1):3-11.
9
Choice of generic versus brand-name antidepressants in a regulated prescription drug market: evidence from Taiwan.在受监管的处方药市场中通用型与品牌型抗抑郁药的选择:来自台湾的证据。
J Ment Health Policy Econ. 2014 Dec;17(4):163-72.
10
Does the use of SSRIs reduce medical care utilization and expenditures?使用选择性5-羟色胺再摄取抑制剂(SSRI)是否会降低医疗服务利用率和支出?
J Ment Health Policy Econ. 2005 Sep;8(3):119-29.

本文引用的文献

1
Amendments to regulations regarding eligibility for a Medicare prescription drug subsidy. Interim final rule with request for comments.医疗保险处方药补贴资格规定的修订。附有征求意见的暂行最终规则。
Fed Regist. 2010 Dec 29;75(249):81843-6.
2
Antidepressant reformulations: who uses them, and what are the benefits?抗抑郁药的新剂型:哪些人使用它们,有哪些益处?
Health Aff (Millwood). 2009 May-Jun;28(3):734-45. doi: 10.1377/hlthaff.28.3.734.
3
Equivalence of generic and brand-name drugs for cardiovascular disease.心血管疾病通用名药物与品牌名药物的等效性。
JAMA. 2009 Apr 22;301(16):1654; author reply 1655-6. doi: 10.1001/jama.2009.520.
4
Inappropriate use of inhaled short acting beta-agonists and its association with patient health status.吸入性短效β受体激动剂的不当使用及其与患者健康状况的关联。
Curr Med Res Opin. 2006 Jan;22(1):33-40. doi: 10.1185/030079905X74934.
5
Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo.与氟西汀、帕罗西汀或安慰剂相比,文拉法辛缓释剂显示出更高的持续缓解率。
Int Clin Psychopharmacol. 2005 Jul;20(4):233-8. doi: 10.1097/00004850-200507000-00007.
6
Evaluating the economic consequences of early antidepressant treatment discontinuation: a comparison between controlled-release and immediate-release paroxetine.评估早期停用抗抑郁药治疗的经济后果:控释帕罗西汀与速释帕罗西汀的比较。
J Clin Psychopharmacol. 2004 Oct;24(5):544-8. doi: 10.1097/01.jcp.0000140999.45053.07.
7
Improving antidepressant adherence.提高抗抑郁药的依从性。
J Clin Psychiatry. 2003;64 Suppl 18:25-30.
8
Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea.速释制剂与控释制剂:新型抗抑郁药的药代动力学与恶心的关系
J Clin Psychiatry. 2003;64 Suppl 18:14-9.
9
Comparison of treatment with fluvastatin extended-release 80-mg tablets and immediate-release 40-mg capsules in patients with primary hypercholesterolemia.原发性高胆固醇血症患者中氟伐他汀缓释80毫克片剂与速释40毫克胶囊治疗的比较。
Clin Ther. 2003 Mar;25(3):904-18. doi: 10.1016/s0149-2918(03)80113-3.
10
Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression.控释和速释帕罗西汀治疗抑郁症的疗效与耐受性
J Clin Psychiatry. 2002 Jul;63(7):577-84. doi: 10.4088/jcp.v63n0707.